ArticleMiddle East journal of digestive diseases2025
The Correlation Between NTCP rs2296651 Variant and Risk of Hepatitis B, Cirrhosis, and Hepatocellular Carcinoma in Iranian Population.
Article in Middle East journal of digestive diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Millions of people are suffering from different types of liver diseases worldwide. Hepatitis B, cirrhosis, and hepatocellular carcinoma (HCC) are the leading causes of death caused by the hepatitis B virus (HBV). HBV needs to interact with the sodium taurocholate co-transporting polypeptide (NTCP) to enter the cytoplasm of the hepatocyte. single nucleotide polymorphism (SNP) with rs2296651 (Ser267Phe, S267F, G>A) variation in the NTCP has been investigated as a reverse association with the function of NTCP and entry of HBV into the cell in the Asian population. We investigated the relationship between the NTCP rs2296651 variant and HBV infection, liver cirrhosis, and HCC in the Iranian population. Methods: Whole blood DNA of 50 healthy individuals as a control group and 90 patients (HBV, cirrhosis, and HCC) were extracted, and the tetra amplification refractory mutation system polymerase chain reaction (tetra-ARMS PCR) was done to identify the genotypes of the samples. Results: Based on our analytical tests using SPSS software, there was a positive and significant association between NTCP rs2296651 in the control group and cirrhosis ( Conclusion: The NTCP rs2296651 variant may confer resistance to HBV infection in the Iranian population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.